Infliximab Videos
newest 100 infliximab videos / infliximab widgets / media rss:

(October 9, 2008 - Insidermedicine) From Munich - According to research from the Cochrane Collaboration, St. John's Wort can effectively treat symptoms of major depression. In a review of 29 studies that included nearly 5,500 participants with major depression, researchers found that those who took St. John's Wort experienced results that were superior to placebo and similar to standard antidepressants. In addition, those who took the herbal remedy experienced fewer side effects. From Orlando - According to research presented at the American College of Gastroenterology, treatment of mild to moderate Crohn's disease with infliximab works better than the immunosuppressant azathioprine. In a study of over 500 patients, researchers found that 30% of those taking azathioprine achieved remission, compared to 44% of those taking infliximab and over 56% of those who received combination therapy. And finally, from California - According to research in the journal Cancer Epidemiology Biomarkers & Prevention, current and former smokers who drink red wine have a lower risk of lung cancer. In a study of over 84,000 men, those who had smoked at least 100 cigarettes in their lifetime and who drank at least one glass of red wine per day had a 60% reduction in lung cancer risk. However, no link was found between lung cancer risk and the consumption of beer, white wine, or liquor. For Insidermedicine in 60, I'm Dr. Susan Sharma.

In this activity, experts on SLE review current and emerging treatments, discuss the latest treatment guidelines from EULAR, and propose therapeutic strategies for patients with lupus nephritis.

In this activity, an expert in the treatment of inflammatory bowel disease looks at the role of biologic therapy in the management of patients with IBD. Pivotal trial data on the approved biologics is reviewed and a look at a number of emerging biologics is presented. In addition, strategies for incorporating biologics into the management of patients with IBD are featured.

In this activity, experts in the treatment of rheumatoid arthritis review recent data on the safety and efficacy of newer biologics for the treatment of patients with this condition.

In this activity, experts in the treatment of rheumatoid arthritis review recent data on the safety and efficacy of newer biologics for the treatment of patients with this condition.

In this activity, experts in the treatment of rheumatoid arthritis review recent data on the newer biologics abatacept and rituximab for the management of this condition.

In this activity, experts present an overview on the management of patients with rheumatoid arthritis who have an inadequate response to traditional DMARD therapy, using newer biologic treatment options.

In this activity, experts in rheumatology present an overview on the management of patients with rheumatoid arthritis (RA), who have an inadequate response to TNF blockers.

In this activity, experts in rheumatology present an overview on the management of patients with rheumatoid arthritis using current and emerging biologic agents.

In this activity, experts in rheumatology present an overview on the management of rheumatoid arthritis with TNF-blockers, with specific focus on early and aggressive treatment. Emphasis is placed on use of monotherapy, combination therapy, step-up strategy, and step-down strategy.